Study: Drug-Coated Stents Perform Well
Posted on: Sunday, 30 March 2008, 21:00 CDT
Drug-coated stents did not increase the risk of death or another heart attack when used to treat heart attack patients, a U.S. study found.
MarketWatch reported Sunday the study compared drug-coated stents to bare-metal stents. The study found that drug-coated stents performed better in preventing a re-narrowing of the cardiac arteries.
Results of the study were announced Sunday at the Society for Cardiovascular Angiography and Intervention's annual conference in Chicago.
The study included two-year, risk-adjusted data from more than 7,200 patients who were treated with stents in Massachusetts hospitals to prop open heart arteries following a heart attack, MarketWatch reported.
Dr. Laura Mauri, an interventional cardiologist at Brigham and Women's Hospital in Boston and lead investigator of the study, said the results were reassuring.
I would feel comfortable considering drug-eluting stents on the basis of these results -- with the caveats that treated patients must be able to take anti-platelet therapy and that we definitely want to see even longer-term term follow up, Mauri said in a statement.
Source: United Press International
Related Articles
- Hospital Care for Heart Attack, Heart Failure Patients Varies Across Nation
- AstraZeneca's Heart Drug Achieves Positive Results in Study
- Merck Reports Encouraging Results in Pivotal Heart Drug Study
- Angioplasty No More Effective Than Combo of Heart Drugs and Exercise: Study
- Heart Transplant Patient Reports Significant Results With Medication and Treatment Compliance Using the ALRT500 Home Health Management System
- Study Questions Safety of Heart Drug
- The Trouble With Heart Drug Studies
- Abbott heart drugs show mixed results, shares fall
- Role of Cholesterol Lowering Drugs in Heart Failure Patients Evaluated in Yale Medical Center's Heart Study
- Study: Heart Drug Use Resulted in Deaths
 |
 |
User Comments (0)
RSS Feeds